1504P - Phase II study to evaluate the peripheral blood mononuclear cell biomarker for nivolumab efficacy on previously treated non-small cell lung cancer subjects (NEJ029B: IMMUNITY-ONE)

Autor:	Kawashima, Y. 1, Yamaguchi, O. 2, Kozuki, T. 3, Furuya, N. 4, Kurimoto, F. 5, Okuno, T. 6, Yamada, T. 7, Komiyama, K. 8, Ko, R. 9, Nagai, Y. 10, Ishikawa, N. 11, Harada, T. 12, Watanabe, K. 13, Seike, M. 14, Yoshimura, K. 15, Kobayashi, K. 2, Kagamu, H. 2
Zdroj:	In Annals of Oncology October 2019 30 Supplement 5:v617-v618
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu